RPGLIFENSERPG Life Sciences Limited· Pharmaceuticals & BiotechnologyHighNegative
Announced Fri, 17 Oct, 2025 · 18:28 IST

CFO Vishal Shah resigns effective October 23, 2025

Cfo ResignedKmp ResignedManagement Changes View source PDFExplain this filing

RPGLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+4.8%Reaction day
₹2295.00
prior close
₹2277.80
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.0%+3.8% vs market
Pharmaceuticals peers, median of 153sector+0.2%+4.6% vs sector

On the reaction day the stock moved 3.8 pts more than Nifty Microcap 250 and 4.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.7
10m
-0.3
15m
-1.0
30m
-1.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+4.8+1.0+3.8+0.2+4.6
Next day
+5.1+2.0+3.1+0.9+4.2
2d
+2.2+1.6+0.7+0.5+1.8
3d
+2.3+1.2+1.1+0.3+2.1
4d
+3.1+1.6+1.5+0.3+2.8
5d
+3.3+1.9+1.4+0.1+3.2
1w
+5.3+2.1+3.1+0.6+4.6
15d
+2.5+1.0+1.4-1.0+3.5
1m
-2.6+0.2-2.8-1.9-0.7
2m
+1.9-3.1+5.0-4.2+6.1
3m
-2.8-10.9+8.1-12.1+9.2
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 153Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

RPG Life Sciences said CFO Vishal Shah will resign at close of business on October 23, 2025, for personal reasons. He also held the role of Key Managerial Personnel, and the company is seeking a replacement. The same board meeting approved unaudited September quarter results: revenue of Rs 181.68 crore, net profit of Rs 36.85 crore, and basic and diluted earnings per share of Rs 22.28.

Likely market impact

CFO Vishal Shah's exit leaves a finance leadership gap until a successor is named and may weigh on investor sentiment.